Episodios

  • GLP-1 Use and AMD Risk

    GLP-1 Use and AMD Risk
    Mar 19 2026
    Could GLP-1s originally designed for diabetes and weight loss influence the risk of developing wet AMD? In this episode of New Retina Radio Journal Club with VBS, host Barton Blackorby, MD, is joined by Katharine Talcott, MD, and Hong-Uyen Hua, MD, to discuss a large national cohort study examining the relationship between GLP-1s and AMD. They explore potential biologic mechanisms, how big-data analyses are shaping retina research, and what these findings could mean for future AMD studies.
    Más Menos
    17 m
  • Spotlight on UNITY® VCS: Intelligent Fluidics

    Spotlight on UNITY® VCS: Intelligent Fluidics
    Mar 16 2026
    In this episode of RetinaLive focused on UNITY® VCS|CS, Jay Sridhar, MD welcomes Steve Charles, MD, FACS, FICS, FASRS and Maria Berrocal, MD for an in-depth conversation on the evolution of vitreoretinal surgery. The panel discusses the historical context of surgical technology, practical considerations for fluidics and intraoperative control, and the importance of adapting techniques for complex cases. Through real-world examples and expert perspectives, listeners will gain valuable insights into surgical decision-making, efficiency and the future of surgical retinal procedures. For Important Product Information, visit unityvcs.com. Disclaimers: Featured surgeons are paid Alcon consultants. The views expressed are their own. 8:57: Compared to HYPERVIT 20K 10:53: 5,000 cSt sillicone oil through 25 Ga cannulas, 1,000 cSt silicone oil through 25 Ga cannulas, up to 80% faster flow rate, all gauges (23 Ga, 25 Ga and 27 Ga entry system), based on bench data 20:45: Compared to CONSTELLATION® Vision System. Based on bench data. References: Alcon Data on File, 2024. [REF-24615] Alcon Data on File, 2024. [REF-24379] Alcon Data on File, 2024. [REF-24576] UNITY VCS and CS User Manual Alcon Data on File, 2024. [REF-24644] Vasavada V, et al. Real-time dynamic intraocular pressure fluctuations during microaxial phacoemulsification using different aspiration flow rates and their impact on early postoperative outcomes: a randomized clinical trial. Journal of Cataract & Refractive Surgery. 2014:30(8);534-540. Vasavada, AR, et al. Impact of high and low aspiration parameters on postoperative outcomes of phacoemulsification randomized clinical trial. Journal of Cataract & Refractive Surgery. 2010:36(4);588-593. Alcon Data on File, 2024. [REF-24899] Alcon Data on File, 2024. [REF-25374] Alcon Data on File, 2025. [REF-28170] NGENUITY 3D Visualization System User Guide 1.5 Manual. Bergamo VC, Caiado RR, Maia A. Et al, role of vital dyes in chromovirectomy. Asia Pac J Ophthalmol. 2021;10(1):26-38. Alcon Data on File, 2024. [REF-25563] Sponsored by Alcon, Inc. © 2026 Alcon Inc. 02/26 US-UVC-2600032
    Más Menos
    22 m
  • The Fellow Eye: Episode 3

    The Fellow Eye: Episode 3
    Mar 5 2026
    Co-hosts David Fell, MD, and Justin C. Muste, MD, are joined by Danny Mammo, MD, and Sean Berkowitz, MD, MBA, to talk all things uveitis, including challenging (and rewarding!) cases. They discuss signs of uveitis masqueraders, when to consider a diagnostic vitrectomy, how to manage patients at risk of being lost to follow-up, and ways to manage endophthalmitis.
    Más Menos
    44 m
  • Mentoring in Retina: Addressing Economic Diversity

    Mentoring in Retina: Addressing Economic Diversity
    Feb 24 2026
    Katherine E. Talcott, MD, sits down with retina mentors Yoshihiro Yonekawa, MD, and Adrienne W. Scott, MD, to discuss various strategies mentors and programs can implement to better support trainees who hale from diverse economic backgrounds.
    Más Menos
    23 m
  • New Retina Radio Journal Club w/ VBS: Outcomes for PDR Patients LTFU for at Least 1 Year

    New Retina Radio Journal Club w/ VBS: Outcomes for PDR Patients LTFU for at Least 1 Year
    Feb 19 2026
    How did patients with PDR fare after being lost to follow-up for at least 1 year and then returning to the clinic? Kyle Kovacs, MD, is joined by Matt Starr, MD, and Nita Valikodath, MD, MS, to explore a recent paper that leveraged the power the IRIS Registry to assess real-world outcomes for this important subset of patients.
    Más Menos
    22 m
  • The Fellow Eye: Episode 2

    The Fellow Eye: Episode 2
    Feb 12 2026
    Podcast co-hosts David Fell, MD, and Justin Muste, MD, are joined by Joshua H. Uhr, MD, and Arnulfo Garza-Reyes, MD, to share their experiences with scleral buckling. They discuss the utility of buckling for various cases, encircling bands versus elements, and tips for surgical success.
    Más Menos
    44 m
  • What I Wish I Knew: Insights From the Next Generation of Retina Specialists

    What I Wish I Knew: Insights From the Next Generation of Retina Specialists
    Feb 5 2026
    Dr. Nemo Patel is joined by Drs. Sam Minaker and Has Al-khersan, who share lessons learned early in their careers about connecting with patients, setting expectations, and integrating therapy for geographic atrophy (GA) secondary to AMD into their respective practices. Together they address how to discuss complex diseases with patients, involve family members in treatment discussions, and build rapport through empathy and transparency. The conversation also highlights practical approaches for team training, workflow efficiency, and addressing real-world challenges in GA care. Please see full Prescribing Information at http://bit.ly/4jXHTsb. This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
    Más Menos
    21 m
  • The Race to Slow GA: A Retina Specialist in the Driver’s Seat of GA Treatment

    The Race to Slow GA: A Retina Specialist in the Driver’s Seat of GA Treatment
    Feb 5 2026
    Are you ready to accelerate your understanding of retina care?Join Dr. Nemo Patel as he speaks with Dr. Patrick Staropoli, a fellow retina specialist and professional race car driver, in an engaging discussion about Geographic Atrophy (GA) secondary to AMD.In this episode, Dr. Staropoli shares how the principles of racing—split-second decision-making, teamwork, and maintaining focus under pressure—influence his approach to treating GA. Together, they'll explore the evolving GA treatment landscape and emphasize the critical role of early detection and timely referral. Please see full Prescribing Information at http://bit.ly/4jXHTsb. This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
    Más Menos
    19 m